Drug Profile
Progesterone transdermal - Transdermal Delivery Solutions
Alternative Names: Progesterone spray - Transdermal Delivery Solutions; Progesterone TDS®Latest Information Update: 24 Aug 2023
Price :
$50
*
At a glance
- Originator Transdermal Delivery Solutions Corp
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Menopausal syndrome; Premenstrual syndrome
Most Recent Events
- 24 Aug 2023 Discontinued - Preclinical for Menopausal syndrome in USA (Transdermal) (Transdermal Delivery Solutions Corp pipeline, August 2023)
- 24 Aug 2023 Discontinued - Preclinical for Premenstrual syndrome in USA (Transdermal) (Transdermal Delivery Solutions Corp pipeline, August 2023)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Menopausal-syndrome in USA (Transdermal, Spray)